JPRN-jRCTs061230021招募中Unknown
A Single-Blind, Crossover Comparative Study of the Efficacy of Jelly Containing the Rare Sugar D-Alulose in Patients with Type 2 Diabetes Mellitus
Fukunaga Kensaku0 个研究点目标入组 24 人开始时间: 2023年6月7日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. patients with type 2 diabetes who are 20 years of age or older at the time of obtaining consent
- •2. patients with type 2 diabetes who are hospitalized in our hospital.
- •3. patients who can give written consent to participate in this study.
排除标准
- •1. patients taking alpha-glucosidase inhibitors
- •2. patients who have experienced serious adverse reactions to D-alulose in the past
- •3. pregnant, lactating, or nursing women, or women of childbearing potential
- •4. patients with severe renal dysfunction (serum eGFR < 15 ml/min/1.73m2)
- •5. patients with other serious complications
- •6. patients who are participating in other studies
- •7. if, in the opinion of the Principal Investigator, participation in the research would not be in the best interest of the research subjects (e.g., would be detrimental to the welfare of the research subjects) or would interfere with, limit, or confound the evaluation specific to the clinical research protocol
- •8. an employee of the Principal Investigator or the institution, or a family member of such an employee or Principal Investigator, who is directly involved in this or other clinical research at the direction of the Principal Investigator or the institution.
研究者
相似试验
进行中（未招募）
1 期
A Randomized, Single-Blinded, Comparative Study of Mycosinate and Curanail in the Treatment of Fungal Nail InfectioOnychomycosisEUCTR2018-000294-78-IEektr Technologies60
进行中（未招募）
不适用
A single-blinded, split-face study for comparative evaluation on the efficacy and stability of the treatment of solar lentigo by picosecond Nd:YAG laser(Picocare 450)KCT0002524WONTECH49
进行中（未招募）
1 期
A Double-Blind, Randomized, Crossover Study of the Recovery of FACTANE 100 versus 200 IU/ml followed by an Open-Label Safety Study of FACTANE 200 IU/ml in Previously Treated Patients With Severe (FVIII:C<1%) Haemophilia AEUCTR2009-013227-28-FRFB BIOTECHNOLOGIES13
已完成
不适用
Effectiveness of Homoeopathic medicines in Allergic Common ColdCTRI/2020/05/025141Vinayaka Missions Research Foundation Deemed to be University
进行中（未招募）
1 期
A Study of Abiraterone Acetate and Prednisone with Androgen Deprivation Therapy (ADT) versus ADT Alone in men newly Diagnosed (within the previous 3 months) with High-Risk, Metastatic (spread of cancer cells from one part of the body to another) Hormone-naive Prostate CancerMetastatic Hormone-Naive Prostate Cancer (mHNPC)MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-002940-26-PTJanssen-Cilag International NV1,270